Baader Bank Aktiengesellschaft Raises Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Baader Bank Aktiengesellschaft grew its stake in Doximity, Inc. (NASDAQ:DOCS) by 85.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,100 shares of the company’s stock after purchasing an additional 5,100 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Doximity were worth $593,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. FMR LLC increased its holdings in shares of Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the period. State Street Corp increased its stake in Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after purchasing an additional 88,922 shares during the period. Geode Capital Management LLC raised its holdings in shares of Doximity by 19.8% in the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after buying an additional 472,565 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Doximity by 4.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock worth $32,808,000 after buying an additional 31,966 shares during the period. Finally, Lord Abbett & CO. LLC purchased a new position in shares of Doximity during the third quarter worth about $29,453,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Up 2.3 %

NASDAQ:DOCS opened at $59.00 on Friday. The stock has a fifty day simple moving average of $54.35 and a 200-day simple moving average of $44.26. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75. The company has a market capitalization of $11.02 billion, a PE ratio of 67.82, a price-to-earnings-growth ratio of 4.43 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.02). Doximity had a net margin of 33.69% and a return on equity of 19.79%. The business had revenue of $136.83 million during the quarter, compared to analyst estimates of $127.05 million. During the same quarter in the prior year, the company earned $0.18 earnings per share. As a group, equities analysts anticipate that Doximity, Inc. will post 0.88 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DOCS. Evercore ISI increased their price objective on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. KeyCorp dropped their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. The Goldman Sachs Group began coverage on shares of Doximity in a research note on Friday, November 15th. They issued a “neutral” rating and a $58.00 target price for the company. Finally, Wells Fargo & Company increased their price target on shares of Doximity from $41.00 to $43.00 and gave the stock an “equal weight” rating in a report on Monday, January 13th. Thirteen investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $53.12.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.